Prediction of CR following a second course of '7+3' in patients with newly diagnosed acute myeloid leukemia not in CR after a first course.

Othus, M; Mukherjee, S; Sekeres, M A; Godwin, J; Petersdorf, S; Appelbaum, F R; Erba, H; Estey, E

Othus, M; Mukherjee, S; Sekeres, M A; Godwin, J; Petersdorf, S; Appelbaum, F R; Erba, H; Estey, E.

Affiliation

Othus M; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Mukherjee S; Leukemia Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
Sekeres MA; Leukemia Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
Godwin J; Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, USA.
Petersdorf S; Seattle Genetics, Seattle, WA, USA.
Appelbaum FR; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Erba H; Division of Hematology & Oncology, University of Alabama, Birmingham, AL, USA.
Estey E; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Leukemia ; 30(8): 1779-80, 2016 08.

Article in En | MEDLINE | ID: mdl-27055872

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Guideline Adherence/statistics & numerical data; Leukemia, Myeloid, Acute/drug therapy; Adult; Aged; Cytarabine/administration & dosage; Daunorubicin/administration & dosage; Female; Humans; Idarubicin/administration & dosage; Male; Middle Aged; Practice Guidelines as Topic

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Guideline Adherence Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2016 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google